Clinical Trial

A Study of Oral E1018 in Healthy Adult Participants

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The primary purpose of the study is to evaluate the safety and tolerability of single ascending oral doses of E1018 in healthy adult participants and to evaluate the pharmacokinetics (PK) of E1018 in plasma and urine after single oral dose administration.
Protocol Amendment History 3 changes
critical Enrollment closed, study ongoing 2026-08-08
notable Primary completion pushed: 2025-12-23 -> 2027-07-22 2026-08-08
minor Completion pushed: 2025-12-23 -> 2027-07-22 2026-08-08
Trial Details
NCT Number NCT06854042
Lead Sponsor Eisai Inc.
Conditions Malaria, Healthy Participants
Enrollment 32 participants
Start Date 2025-02-26
Primary Completion 2027-07-22 (estimated)
Study Completion 2027-07-22 (estimated)
Updated on ClinicalTrials.gov 2026-08-07